News

250109_Monoclonal Antobody.jpg
Jan. 10, 2025 Never diffuse alone: understanding antibody teamwork to design tomorrow's therapeutics
Monoclonal antibodies (mAbs) are used to treat a large variety of diseases. In order to allow patients to inject these therapeutic molecules autonomously, it is crucial to understand the origin of and to control their viscosity. An international team of researchers used an interdisciplinary approach to understand how molecular interactions and motions influence the viscosity of different mAbs. The study has now been published in the journal Molecular Pharmaceutics.